Latest Kynam Capital Management, LP Stock Portfolio
$902Million
Equity Portfolio Value
Last Reported on: 14 Feb, 2024
About Kynam Capital Management, LP and it’s 13F Hedge Fund Stock Holdings
In it's latest 13F Holdings report, Kynam Capital Management, LP reported an equity portfolio of $611.4 Millions as of 30 Sep, 2023.
The top stock holdings of Kynam Capital Management, LP are NTRA, CLDX, PCVX. The fund has invested 21.7% of it's portfolio in NATERA INC and 14.4% of portfolio in CELLDEX THERAPEUTICS INC NEW.
The fund managers got completely rid off RHYTHM PHARMACEUTICALS INC (RYTM) and NEOLEUKIN THERAPEUTICS INC (NLTX) stocks. They significantly reduced their stock positions in OLEMA PHARMACEUTICALS INC (OLMA), TRAVERE THERAPEUTICS INC (TVTX) and VERA THERAPEUTICS INC (VERA). Kynam Capital Management, LP opened new stock positions in ACELYRIN INC, TAYSHA GENE THERAPIES INC (TSHA) and DYNAVAX TECHNOLOGIES CORP (DVAX). The fund showed a lot of confidence in some stocks as they added substantially to PROTAGONIST THERAPEUTICS INC (PTGX), COGENT BIOSCIENCES INC (COGT) and CELLDEX THERAPEUTICS INC NEW (CLDX).
The top stock holdings of Kynam Capital Management, LP are NTRA, CLDX, PCVX. The fund has invested 21.7% of it's portfolio in NATERA INC and 14.4% of portfolio in CELLDEX THERAPEUTICS INC NEW.
The fund managers got completely rid off RHYTHM PHARMACEUTICALS INC (RYTM) and NEOLEUKIN THERAPEUTICS INC (NLTX) stocks. They significantly reduced their stock positions in OLEMA PHARMACEUTICALS INC (OLMA), TRAVERE THERAPEUTICS INC (TVTX) and VERA THERAPEUTICS INC (VERA). Kynam Capital Management, LP opened new stock positions in ACELYRIN INC, TAYSHA GENE THERAPIES INC (TSHA) and DYNAVAX TECHNOLOGIES CORP (DVAX). The fund showed a lot of confidence in some stocks as they added substantially to PROTAGONIST THERAPEUTICS INC (PTGX), COGENT BIOSCIENCES INC (COGT) and CELLDEX THERAPEUTICS INC NEW (CLDX).
New Buys
| Ticker | $ Bought |
|---|---|
| IMMUNOGEN INC | 42,177,200 |
| MORPHOSYS AG | 41,923,400 |
| TYRA BIOSCIENCES INC | 4,711,630 |
New stocks bought by Kynam Capital Management, LP
Additions
Additions to existing portfolio by Kynam Capital Management, LP
Reductions
| Ticker | % Reduced |
|---|---|
| CENTESSA PHARMACEUTICALS PLC | -39.39 |
| VAXCYTE INC | -23.03 |
| NATERA INC | -20.1 |
| VIRIDIAN THERAPEUTICS INC | -13.12 |
| CELLDEX THERAPEUTICS INC NEW | -6.07 |
Kynam Capital Management, LP reduced stake in above stock
Sold off
| Ticker | $ Sold |
|---|---|
| TAYSHA GENE THERAPIES INC | -10,368,900 |
| CONNECT BIOPHARMA HLDGS LTD | -434,003 |
| PUMA BIOTECHNOLOGY INC | -1,246,550 |
| GOSSAMER BIO INC | -208,200 |
| OLEMA PHARMACEUTICALS INC | -2,904,420 |
| CATALYST BIOSCIENCES INC | -43,435 |
| NEOLEUKIN THERAPEUTICS INC | -94,946 |
Kynam Capital Management, LP got rid off the above stocks
Current Stock Holdings of Kynam Capital Management, LP
Last Reported on: 14 Feb, 2024| Ticker | Namesorted ascending | % Portfolio | Shares Held | $ Value | Type | % Change | Options |
|---|---|---|---|---|---|---|---|
| AMRN | AMARIN CORP PLC | 1.16 | 12,023,000 | 10,460,000 | UNCHANGED | 0.00 | |
| BCRX | BIOCRYST PHARMACEUTICALS INC | 3.05 | 4,600,000 | 27,554,000 | ADDED | 46.82 | |
| BNR | BURNING ROCK BIOTECH LTD | 0.90 | 8,694,430 | 8,085,820 | ADDED | 2.29 | |
| CBIO | CATALYST BIOSCIENCES INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| CLDX | CELLDEX THERAPEUTICS INC NEW | 13.21 | 3,005,900 | 119,214,000 | REDUCED | -6.07 | |
| CNTA | CENTESSA PHARMACEUTICALS PLC | 0.39 | 442,704 | 3,523,920 | REDUCED | -39.39 | |
| CNTB | CONNECT BIOPHARMA HLDGS LTD | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| COGT | COGENT BIOSCIENCES INC | 3.81 | 5,854,770 | 34,426,000 | ADDED | 164 | |
| CRBU | CARIBOU BIOSCIENCES INC | 0.68 | 1,068,530 | 6,122,660 | UNCHANGED | 0.00 | |
| DVAX | DYNAVAX TECHNOLOGIES CORP | 2.35 | 1,514,380 | 21,171,100 | ADDED | 202 | |
| GOSS | GOSSAMER BIO INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| IMGN | IMMUNOGEN INC | 4.67 | 1,422,500 | 42,177,200 | NEW | ||
| LQDA | LIQUIDIA CORPORATION | 3.60 | 2,698,320 | 32,460,800 | ADDED | 34.92 | |
| MOR | MORPHOSYS AG | 4.64 | 4,234,680 | 41,923,400 | NEW | ||
| NLTX | NEOLEUKIN THERAPEUTICS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| NTRA | NATERA INC | 16.66 | 2,400,000 | 150,336,000 | REDUCED | -20.1 | |
| OLMA | OLEMA PHARMACEUTICALS INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| PBYI | PUMA BIOTECHNOLOGY INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| PCVX | VAXCYTE INC | 6.97 | 1,002,410 | 62,951,200 | REDUCED | -23.03 | |
| PTGX | PROTAGONIST THERAPEUTICS INC | 5.09 | 2,004,880 | 45,971,800 | ADDED | 10.24 | |
| SNDX | SYNDAX PHARMACEUTICALS INC | 13.55 | 5,660,000 | 122,313,000 | ADDED | 57.22 | |
| STRO | SUTRO BIOPHARMA INC | 0.95 | 2,001,730 | 8,587,410 | ADDED | 28.92 | |
| TSHA | TAYSHA GENE THERAPIES INC | 0.00 | 0.00 | 0.00 | SOLD OFF | -100 | |
| TSVT | 2SEVENTY BIO INC | 2.82 | 5,953,820 | 25,422,800 | UNCHANGED | 0.00 | |
| TVTX | TRAVERE THERAPEUTICS INC | 1.99 | 2,000,000 | 17,980,000 | ADDED | 108 | |
| TYRA | TYRA BIOSCIENCES INC | 0.52 | 340,190 | 4,711,630 | NEW | ||
| VERA | VERA THERAPEUTICS INC | 6.22 | 3,650,340 | 56,142,200 | ADDED | 23.49 | |
| VRDN | VIRIDIAN THERAPEUTICS INC | 1.47 | 607,915 | 13,240,400 | REDUCED | -13.12 | |
| WVE | WAVE LIFE SCIENCES LTD | 2.20 | 3,932,080 | 19,857,000 | UNCHANGED | 0.00 | |
| ACELYRIN INC | 0.99 | 1,200,000 | 8,952,000 | UNCHANGED | 0.00 |